Cargando…
More Than a Metabolic Enzyme: MTHFD2 as a Novel Target for Anticancer Therapy?
The bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase (MTHFD2) is a mitochondrial one-carbon folate metabolic enzyme whose role in cancer was not known until recently. MTHFD2 is highly expressed in embryos and a wide range of tumors but has low or absent expression in most adult di...
Autores principales: | Zhu, Zhiyuan, Leung, Gilberto Ka Kit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199629/ https://www.ncbi.nlm.nih.gov/pubmed/32411609 http://dx.doi.org/10.3389/fonc.2020.00658 |
Ejemplares similares
-
Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer
por: Zhang, Hao, et al.
Publicado: (2023) -
Whether MTHFD2 plays a new role: from anticancer targets to anti-inflammatory disease
por: Tang, Hui, et al.
Publicado: (2023) -
MTHFD1L-Mediated Redox Homeostasis Promotes Tumor Progression in Tongue Squamous Cell Carcinoma
por: Li, Hao, et al.
Publicado: (2019) -
Targeting MTHFD2 in acute myeloid leukemia
por: Pikman, Yana, et al.
Publicado: (2016) -
Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer
por: Nilsson, Roland, et al.
Publicado: (2014)